Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept

被引：0
|
作者：
Llinares-Tello, Francisca [1 ]
Rosas-Gomez de Salazar, Jose [2 ]
Miguel Senabre-Gallego, Jose [2 ]
Santos-Soler, Gregorio [2 ]
Santos-Ramirez, Carlos [4 ]
Salas-Heredia, Esteban [2 ]
Molina-Garcia, Juan [3 ]
机构：
[1] Marina Baixa Hosp, Dept Lab, Alicante 03570, Spain
[2] Marina Baixa Hosp, Dept Rheumatol, Alicante, Spain
[3] Marina Baixa Hosp, Dept Lab, Alicante, Spain
[4] Marina Salud Hosp, Dept Rheumatol, Alicante, Spain
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2015年 / 53卷 / 10期
关键词：
ELISA; etanercept; therapeutic drug monitoring; COMMERCIALLY AVAILABLE METHODS; RHEUMATOID-ARTHRITIS; ADALIMUMAB; INFLIXIMAB;
D O I：
10.1515/cclm-2014-0898
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：E279 / E282
页数：4
相关论文
共 50 条
  • [31] Editorial: Advances in therapeutic drug monitoring of psychiatric subjects: Analytical strategies and clinical approaches
    Mercolini, Laura
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [32] Evaluation of the Analytical Performance of Two Therapeutic Drug Monitoring Assays on the Atellica CI Analyzer
    Huff, J.
    Valdivia, B.
    Wilkins, G.
    Arrode-Bruses, G.
    Leipold, H.
    Snyder, J.
    CLINICAL CHEMISTRY, 2024, 70 : I242 - I242
  • [33] Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring
    Holt, David W.
    Mandelbrot, Didier A.
    Tortorici, Michael A.
    Korth-Bradley, Joan M.
    Sierka, Debra
    Levy, Daniel I.
    Tai, Sandi See
    Horowitz, Gary L.
    CLINICAL TRANSPLANTATION, 2014, 28 (02) : 243 - 251
  • [34] Therapeutic drug monitoring in clinical research
    Neef C.
    Touw D.J.
    Stolk L.M.
    Pharmaceutical Medicine, 2008, 22 (4) : 235 - 244
  • [35] THERAPEUTIC DRUG MONITORING IN THE CLINICAL LABORATORY
    KARMEN, A
    LONGO, NS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (APR): : 5 - 5
  • [36] THERAPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY
    Ahlner, J.
    Aamo, T. O.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 16 - 16
  • [37] NEW GUIDANCE ON THERAPEUTIC DRUG MONITORING; POTENTIAL CLINICAL AND COST IMPLICATIONS
    Felwick, Richard
    Johnson, Heather
    Dewhurst, Hannah
    Cadogan, Ernest
    Hovell, Chris
    Weaver, Sean
    McLaughlin, Simon
    GUT, 2018, 67 : A76 - A77
  • [38] New guidance on therapeutic drug monitoring; potential clinical and cost implication
    Felwick, R.
    Johnson, H.
    Dewhurst, H.
    Cadogan, E.
    Hovell, C.
    Weaver, S.
    McLaughlin, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S371 - S371
  • [39] Performance evaluation of New Dimension® platform for therapeutic drug monitoring of tacrolimus
    Buitrago, E. F.
    Otamendi, E.
    Bramuglia, G.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 543 - 543
  • [40] Dried Plasma Spots and Oral Fluid as Alternative Matrices for Therapeutic Drug Monitoring of Busulfan: Analytical Method Development and Clinical Evaluation
    Granzotto, Fabiana C. N.
    da Silva, Anne C. C.
    Lizot, Lilian F.
    Antunes, Marina, V
    Linden, Rafael
    THERAPEUTIC DRUG MONITORING, 2021, 43 (03) : 376 - 385
12345